The iconic rise of Viagra has consistently remained a example of pharmaceutical success, but its legacy within the broader industry now presents questions about long-term gains. Alternative versions are undercutting market share, causing anxieties that supporting companies heavily reliant to Viagra's once-dominant standing could be a dangerous move